| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-07 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.15 | 9e-05 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.2 | 0.0001 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |